Galli Ad 0.74 – 3.70 GBq
Galli Ad 0.74 – 3.70 GBq is a medicine authorised by Swissmedic under authorisation number 70362. The authorisation holder is b.e.imaging.ag. The medicinal product code is Radiopharmaceuticals and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 August 2026 and the authorisation is limited until 24 August 2031. ATC code V09X places the medicine in the group Diagnostic radiopharmaceuticals.
| Authorisation number | 70362 |
|---|---|
| Name | Galli Ad 0.74 – 3.70 GBq |
| Full name | Galli Ad 0.74 – 3.70 GBq, Radionuklidgenerator |
| Authorisation holder | b.e.imaging.ag |
| Medicinal product code | Radiopharmaceuticals |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | V09X |
| First authorisation | 25 August 2026 |
| Authorisation validity | 24 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Galli Ad 0.74 – 3.70 GBq, Radionuklidgenerator | A | 25 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Gerät | V09X | 17.03. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Galli Ad 0.74 – 3.70 GBq authorised in Switzerland?
Yes. Galli Ad 0.74 – 3.70 GBq is authorised by Swissmedic under authorisation number 70362, data as of 01 September 2026. The authorisation is limited until 24 August 2031.
Which dispensing category does Galli Ad 0.74 – 3.70 GBq have?
Galli Ad 0.74 – 3.70 GBq is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Galli Ad 0.74 – 3.70 GBq?
The authorisation holder is b.e.imaging.ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.